Stage 5 Chronic Kidney Disease Clinical Trial
Official title:
Frailty, Cardiovascular Function and Risk of Falling in Patients Receiving Haemodialysis Treatment
| NCT number | NCT02392299 |
| Other study ID # | BUR(14/17) |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | September 2015 |
| Est. completion date | August 29, 2018 |
| Verified date | August 2018 |
| Source | Queen Margaret University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The purpose of this study is to explore the relative importance of the frailty and cardiovascular function as potential exercise-modifiable risk factors for falling in patients receiving haemodialysis.
| Status | Completed |
| Enrollment | 93 |
| Est. completion date | August 29, 2018 |
| Est. primary completion date | August 29, 2018 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - 18 years old - Able to write/speak fluent English - Stable dialysis Exclusion Criteria: - Unstable dialysis and medication treatment - Lower limb amputees without prothesis - Unstable cardiac condition - Suspected or known aneurysm - Clinically severe left ventricular outflow obstruction - Critical mitral stenosis - Critical proximal coronary artery stenosis - Critical cerebrovascular stenosis - Pregnancy - Severe cognitive impairment |
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | Monklands Renal Unit | Airdrie | |
| United Kingdom | Renal Unit | Falkirk |
| Lead Sponsor | Collaborator |
|---|---|
| Queen Margaret University | British Kidney Patient Association, British Renal Society |
United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Cardiovascular Function | blood pressure, baroreceptor reflexes | baseline | |
| Primary | Falls incidence | One year | ||
| Secondary | Frailty components | muscle strength, balance, gait speed, body composition | baseline |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03602261 -
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
|
Phase 2 | |
| Completed |
NCT02392208 -
Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
|
Phase 4 | |
| Active, not recruiting |
NCT01587443 -
Comparison of Outcomes Between Hemodialysis and Peritoneal Dialysis Patients in a Multi-Ethnic Asian Population
|
N/A | |
| Recruiting |
NCT01509690 -
Impact of a Multidisciplinary Intensive Management Clinic on Outcomes in Multi-Ethnic Asian Incident Hemodialysis Patients
|
Phase 2/Phase 3 |